Blackrock Health Sciences Term Trust DEF 14A proxy statements

BlackRock's closed-end funds are holding a joint virtual annual meeting on July 22, 2026, to elect nominees to their Boards of Directors/Trustees.

BlackRock Closed-End Funds will hold a virtual joint annual meeting of shareholders on July 11, 2025, to vote on the election of board nominees.

BlackRock urges shareholders to vote in favor of its board nominees and against a proposal by Saba Capital to terminate BlackRock as investment manager, highlighting the fund's performance and discount management program.

Glass Lewis recommends voting for BlackRock's board nominees and against Saba Capital's proposals to terminate BlackRock as investment adviser for ten closed-end funds.

BlackRock Health Sciences Term Trust files a definitive proxy statement with the Securities and Exchange Commission.

Institutional Shareholder Services (ISS) recommends shareholders vote against Saba Capital's proposals to terminate BlackRock as investment adviser for multiple closed-end funds and supports BlackRock's board nominees.

BlackRock is urging shareholders of the Health Sciences Term Trust (BMEZ) to vote against a hedge fund's attempt to install its own board nominees, claiming it could harm long-term investment value.

BlackRock is urging shareholders to vote against Saba Capital's proposals to install its own nominees and potentially terminate BlackRock's management of certain closed-end funds.

BlackRock urges shareholders to vote for its board nominees and against Saba Capital's proposals in the upcoming annual meetings for its contested closed-end funds (CEFs).

BlackRock Advisors, LLC is urging shareholders of ten closed-end funds to vote on upcoming proposals in line with the Board's recommendations.

BlackRock is actively defending its closed-end funds (CEFs) against a proxy fight initiated by Saba Capital Management, emphasizing the value and unique benefits these funds offer to shareholders.

BlackRock urges shareholders to vote against Saba Capital's proposal to terminate the investment management agreement for the BlackRock Health Sciences Term Trust (BMEZ), highlighting BMEZ's outperformance and value delivery.

BlackRock Health Sciences Term Trust urges shareholders to vote in favor of BlackRock's board nominees and against Saba Capital's proposal to terminate the investment management agreement.

BlackRock urges shareholders to vote against Saba Capital's proposals to install its own nominees and terminate BlackRock's investment management agreements for certain closed-end funds.

BlackRock is actively defending its closed-end fund governance practices against demands from Saba Capital, highlighting ongoing settlement negotiations and actions to enhance shareholder value.

BlackRock Health Sciences Term Trust is urging shareholders to vote FOR BlackRock's board nominees and AGAINST Sabas' proposal to protect their need for steady income.

BlackRock urges shareholders to vote against Saba Capital's proposal to terminate BlackRock's investment management agreement for the Health Sciences Term Trust (BMEZ).

BlackRock is actively defending its closed-end funds against a proxy challenge from Saba Capital Management, emphasizing the funds' value proposition and the board's commitment to shareholder interests.

BlackRock urges shareholders to vote for its board nominees and against Saba Capital's proposals, arguing that Saba's actions are self-serving and could harm long-term shareholder value.

BlackRock Health Sciences Term Trust urges shareholders to vote against Saba Capital's proposal to replace the board and terminate BlackRock as the fund's manager, emphasizing a recent distribution rate increase.

BlackRock is actively defending against activist hedge fund Saba Capital Management's proxy contests aimed at installing its own director nominees and replacing BlackRock as fund manager for certain closed-end funds.

BlackRock Health Sciences Term Trust amends its proxy statement to reflect a court decision impacting the applicability of the Maryland Control Share Acquisition Act to the Trust's upcoming shareholder meetings.

BlackRock addresses concerns regarding proxy voting and shareholder access in its Health Sciences Term Trust.

BlackRock is actively campaigning against activist hedge fund Saba Capital, which is seeking to disrupt several BlackRock-managed closed-end funds.

Saba Capital Management is attempting to install its own board nominees and replace BlackRock as manager of the BlackRock Health Sciences Term Trust (BMEZ), threatening the fund's income and investment strategy.

BlackRock is urging shareholders to vote against Saba Capital Management's proposals to elect its own board nominees and terminate BlackRock's investment management agreements for certain closed-end funds.

BlackRock Health Sciences Term Trust expresses disappointment over arbitrage investors attempting to manipulate closed-end funds for short-term gains at the expense of long-term retail shareholders.

BlackRock Health Sciences Term Trust is urging shareholders to vote against Saba Capital's nominees and proposal to terminate BlackRock as investment advisor, citing potential harm to the fund and its distributions.

Activist hedge fund Saba Capital Management is attempting to replace BlackRock as the investment advisor for the BlackRock Health Sciences Term Trust (BMEZ), prompting BlackRock to urge shareholders to vote using the WHITE proxy card to retain the current board and investment management agreement.

BlackRock Health Sciences Term Trust amended its proxy statement to include a standstill agreement with Karpus Management, involving a discount management program with potential tender offers.